Category: General

Magic Johnson-Backed Startup Raises $31 Million to Help Build, Expand In-House Pharmacies at 340B HIV Clinics

October 22, 2024 Bella Czajkowski, National Correspondent Views

Alchemy announced that it has raised $31 million, as part of a campaign with NBA legend Earvin “Magic” Johnson, to help build in-house pharmacies for HIV clinics. (Credit: Shutterstock)

A California-based healthcare startup recently announced that it has raised more than $30 million, as part of a campaign with [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest

October 22, 2024 Shannon Young, Associate Editor/Senior Writer Views

More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.

The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Dark Money Poured Nearly $4M into Super PAC Opposing State 340B Contract Pharmacy Access Bills

October 18, 2024 William Newton, Associate Editor/Senior Writer Views

Stand for US PAC received $3.8 million in contributions over the last three months from a conservative dark money group.

A political action committee (PAC) that funded efforts opposing state 340B contract pharmacy access bills through misleading claims linking the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

LA Times Says ‘No’ to California Ballot Measure That Would Affect 340B

October 18, 2024 Shannon Young, Associate Editor/Senior Writer Views

The Los Angeles Times’ editorial board endorsed the “no” position on Proposition 34, a 340B-realated measure which will appear on the Nov. 5 ballot.

An influential California newspaper recently urged against a November ballot measure, which would require certain healthcare providers in the state [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Health Leader Slams J&J Rebate Proposal, Urges Providers to ‘Remain Vigilant’ in Op-Ed

October 16, 2024 Shannon Young, Associate Editor/Senior Writer Views

Maureen Testoni, the president and CEO of 340B Health celebrated J&J’s retreat from a 340B rebate proposal in an Oct. 9 RACmonitor op-ed.

The head of an influential 340B hospital advocacy group claimed “victory” in the recent fight against Johnson & Johnson’s (J&J) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers Raise Caution on Claims Data Submission Requirements After 340B ESP Terms of Use Update Continues to Defer to Manufacturers

October 16, 2024 Shannon Young, Associate Editor/Senior Writer Views

Second Sight Solutions updated 340B ESP's terms of use on Oct. 4.

Editor’s Note: An earlier version of this story incorrectly suggested that an Oct. 4 update to 340B ESP’s terms of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Centers Urge Federal Appeals Court to Take Their Side in Case Alleging Drug Manufacturer Collusion on Contract Pharmacy Restrictions

October 16, 2024 Bella Czajkowski, National Correspondent Views

Two community health centers argued in a Sept. 30 filing with the U.S. 2nd Circuit Court of Appeals that diabetes drugmakers colluded to place contract pharmacy restrictions.

Two community health centers urged a federal appeals court to overturn the dismissal of their 340B antitrust lawsuit, arguing in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Orders and Filings in Arkansas, Louisiana, Kansas, Mississippi Maryland, Missouri

October 10, 2024 Shannon Young, Associate Editor/Senior Writer & William Newton, Associate Editor/Senior Writer & Bella Czajkowski, National Correspondent Views

Key motions were filed this week in state contract pharmacy litigation in Arkansas, Maryland, Louisiana, Kansas, Missouri, Minnesota and Mississippi.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Head of Drug Industry-Funded Think Tank Backs J&J’s Proposed Rebate Model, Slams Hospitals in Op-Ed

October 10, 2024 Shannon Young, Associate Editor/Senior Writer Views

Sally Pipes, the president and CEO of the drug-industry funded Pacific Research Institute, criticized pushback that led Johnson & Johnson to forgo its plans to implement a 340B rebate model in an Oct. 7 Forbes op-ed.

The leader of a right-leaning think tank that’s received funding from the drug industry criticized pushback that led Johnson & [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Announces Specialty Pharmacy Senderra No Longer Eligible to Dispense Asthma Drug

October 8, 2024 Bella Czajkowski, National Correspondent Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

Specialty pharmacy Senderra Rx will no longer dispense GlaxoSmithKline’s (GSK’s) asthma treatment Nucala, the drug manufacturer announced on industry vendor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live